Clinical trials
Phase 2 Obesity trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 4 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carmot Therapeutics, Inc. | 2 |
| Eli Lilly and Company | 2 |
| Laboratorios Silanes S.A. de C.V. | 2 |
| Centro Universitario de Ciencias de la Salud, Mexico | 1 |
| Cindetec | 1 |
| Coordinación de Investigación en Salud, Mexico | 1 |
| Galmed Research and Development, Ltd. | 1 |
| Hospital Juarez de Mexico | 1 |
| Hospital Nacional Homeopático, Mexico | 1 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 15 |
| Overweight | 7 |
| Diabetes Mellitus, Type 2 | 6 |
| Diabetes Mellitus | 4 |
| Body Weight | 2 |
| Hypertension | 2 |
| Body Weight Changes | 1 |
| COVID-19 | 1 |
| Dyslipidemias | 1 |
| Endocrine System Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.